• We are a biotech company in
    infectious diseases with
    two marketed products.

  • Dedicated to innovation in
    vaccine research & development.

  • Valneva covers the full
    value chain from bench
    to market.

 

Welcome to Valneva

A leading pure play vaccine biotech company.

VAL_Banner_ABR2014_small.jpg

— August 27, 2015

Valneva Announces Two New EB66® Agreements; 7 new EB66® deals signed since the beginning of the year

Read more

— Stock information

@valnevase




















-

—News, July 23, 2015

Valneva and PaxVax Enter into Marketing and Distribution Agreement

 Read more

— Financial calendar


August 31, 2015  
Valneva will publish its half-year financial results on Monday, August 31, 2015. A conference call will be held on that day at 2 pm (CET) and can be followed here.



All dates     
                                                                                        


 

play video Valneva's CEO Thomas Lingelbach
comments on Group Strategy

– Upcoming conferences and fairs


Biopharma
Boston, U.S.
15-17 September, 2015

BIO-Europe
Munich, Germany
2–4 November, 2015 

World Vaccine Congress Europe
Madrid, Spain
9-11 November 2015

Jefferies Autumn 2015 Global Healthcare Conference London, UK
18-19 November, 2015




map

European pure vaccine player with international footprint.

Locations
Please update your browser...